Page last updated: 2024-09-03

mozavaptan and tetradecanoylphorbol acetate

mozavaptan has been researched along with tetradecanoylphorbol acetate in 1 studies

Compound Research Comparison

Studies
(mozavaptan)
Trials
(mozavaptan)
Recent Studies (post-2010)
(mozavaptan)
Studies
(tetradecanoylphorbol acetate)
Trials
(tetradecanoylphorbol acetate)
Recent Studies (post-2010) (tetradecanoylphorbol acetate)
16582431,050612,217

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirai, S; Kosaka, K; Mizuno, K; Nishioka, N; Ohno, S; Osada, S; Suzuki, A1

Other Studies

1 other study(ies) available for mozavaptan and tetradecanoylphorbol acetate

ArticleYear
Wortmannin inhibits the activation of MAP kinase following vasopressin V1 receptor stimulation.
    FEBS letters, 1995, Dec-27, Volume: 377, Issue:3

    Topics: Androstadienes; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Fibroblasts; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Piperidines; Quinolones; Rats; Receptors, Vasopressin; Signal Transduction; Tetradecanoylphorbol Acetate; Wortmannin

1995